Millipore Sigma Vibrant Logo
 

antibodies


15313 Results 詳細検索  
種類別絞り込み
製品情報 (9.872)
技術資料 (5.267)
関連ページ (174)
お探しのものが見つかりませんか？
カスタマーサービスへの
お問合せ

 

  • Small GTPase Activation Assays | Life Science Research | Merck

    Cytoskeletal signaling complexes include G-protein complexes, focal adhesions, and adherens junctions. Focal adhesions and adherens junctions link the cell exterior to the plasma membrane and the actin cytoskeleton, acting as key initiators of signaling pathways in response to cell adhesion.

  • RIPAb+ | Life Science Research | Merck

    All RIPAb+ antibodies are validated for RNA-binding protein immunoprecipitation. Each RIPAb+ antibody set includes control primers (each lot tested by qPCR) to biologically validate your RNA RIP results by qPCR detection of specific RNAs where possible

  • ChIP Ab+ | Life Science Research | Merck

    ChIP Ab+ antibodies avoid ChIP failure due to poor antibody performance. Each ChIPAb+ antibody set includes control primers to validate your ChIP results and a negative control antibody to confirm specificity of the reaction.

  • New Antibodies and Small Molecules | Life Science Research | Merck

    Merck develops new antibodies and small molecules to support advance research. Scientist needs precise, dependable antibodies to study the latest targets and discover new molecules. At Merck, our scientists evaluate potential antibody targets to determine if our customers can benefit from new antibody target developments. We then work to produce specific, validated antibodies for success in various research applications.

  • Research Areas | Life Science Research | Merck

    Antibodies have been a critical tools for most areas of life science research. The basic principle of any immunochemical technique is that a specific antibody will combine with its specific antigen to generate an exclusive antibody-antigen complex. The nature of this bond is a molecular tag for used in every biological research areas. We have a very strong, interactive customer base that continuously requests new or modified antibody targets for research that matters to them. Your research motivates our search for, and development of antibodies that advance science - one target at a time. Our portfolio contains over 10,000 quality antibodies.